Ras Proteins in Nerve Tumorigensis
Ras Proteins in Nerve Tumorigensis
批准号:
9899332
负责人:
NANCY RATNER
金额:
$39.75万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-01 至 2021-04-30
关键词:
AffectAllelesAutomobile DrivingBenignBrainBrain NeoplasmsCause of DeathCell ProliferationCell modelCellsCommon NeoplasmCytokine SignalingDataDefectDevelopmentDifferentiation and GrowthDiseaseFibroblastsGTP BindingGTPase-Activating ProteinsGene MutationGenesGeneticGenetic ModelsGoalsGuanosine TriphosphateHematopoieticHistologicHumanIn VitroIndividualInheritedInterventionKnock-inLungMEKsMediatingMissense MutationModelingMolecularMusMutationNF1 geneNF1 mutationNF1 tumor suppressorNerveNeuroblastomaNeurofibromatosis 1PathogenesisPathway interactionsPatientsPeripheral Nerve SheathPeripheral NervesPhenotypePheochromocytomaPoint MutationProtein IsoformsProteinsProto-Oncogene Proteins c-aktRAS genesRRAS2 geneRoleSchwann CellsSignal PathwaySignal TransductionSorting - Cell MovementSpinal GangliaSurvival AnalysisSystemTamoxifenTestingThyroid GlandWorkautocrinec-Ha-ras p21cancer cellcytokineexome sequencingin vivoloss of functionloss of function mutationmigrationmouse modelmutantneoplastic cellneurofibromanovelpublic health relevanceras Proteinsrecruitsarcomaself-renewaltherapy resistanttumortumor growthtumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Ras proteins are molecular switches that in their GTP-bound state control intracellular signaling cascades. Ras signaling is inactivated by GTPase-activating proteins (GAPs), including the tumor suppressor NF1. NF1 loss of function mutations have recently been implicated in driving neuroblastoma, brain, lung, thyroid and other tumor types and implicated in resistance to therapy. In addition, inherited NF1 mutations result in Neurofibromatosis type 1, a disease in which patients develop incurable benign peripheral nerve sheath Schwann cell tumors called neurofibromas. NF1 patients are also predisposed to aggressive sarcomas, MPNST, which are a leading cause of death in NF1 patients. The goals of this application are two-fold. We shall use NF1 loss of function to delineate Ras-specific pathways in neurofibroma cells. This is because NF1 is a GAP for all Ras proteins: H-, N-, K-, M-, R-Ras and RRas2/TC21, and may have additional, non-Ras, functions. When there is complete loss of NF1, all Ras proteins are activated, so that NF1 models provide a unique opportunity to study the contributions of individual Ras proteins to tumorigenesis in vivo. In Aim 1 we will test whether loss of H-Ras specifically delays or blocks neurofibroma formation in mouse models driven by NF1 loss of function, alone or in combination with RRas2 loss. We will also determine if H-Ras activation is sufficient to promote neurofibroma formation. In Aim 2 we will test if Ras activation is sufficient for neurofibroma formation, using a new Nf1 mutant allele and use specialized Schwann cell systems to define Ras-specific effects in NF1 mutant cells. In Aim 3 we will validate our state-of-the-art exome sequencing to identify Ras-related signaling pathway mutations in Schwann cells that co-operate with NF1 loss of function to promote NF1 tumorigenesis. Together these studies will define Ras isoform specific functions in cancer cells, and clarify molecular signals that drive neurofibroma formation.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1186/s40478-018-0635-9
发表时间:
2018-11-23
期刊:
Acta neuropathologica communications
影响因子:
7.1
作者:
[Coover RA, Healy TE, Guo L, Chaney KE, Hennigan RF, Thomson CS, Aschbacher-Smith LE, Jankowski MP, Ratner N]
通讯作者:
Ratner N
Identification of novel pathways causing NF1-driven Schwann cell tumors
-
批准号:10531621
-
项目类别:
-
资助金额:$50.06万
-
财政年份:2021
-
负责人:NANCY RATNER
-
依托单位:
Identification of novel pathways causing NF1-driven Schwann cell tumors
-
批准号:10361597
-
项目类别:
-
资助金额:$50.06万
-
财政年份:2021
-
负责人:NANCY RATNER
-
依托单位:
Targeting Complement 5a-Mediated Immunoregulation for Neurofibroma Therapy
-
批准号:10400915
-
项目类别:
-
资助金额:$39.12万
-
财政年份:2019
-
负责人:NANCY RATNER
-
依托单位:
Targeting complement 5a-mediated immunoregulation for neurofibroma therapy
-
批准号:9807327
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2019
-
负责人:NANCY RATNER
-
依托单位:
Targeting Complement 5a-Mediated Immunoregulation for Neurofibroma Therapy
-
批准号:10320559
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2019
-
负责人:NANCY RATNER
-
依托单位:
Ras Proteins in Nerve Tumorigensis
-
批准号:8804962
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2014
-
负责人:NANCY RATNER
-
依托单位:
Ras Proteins in Nerve Tumorigensis
-
批准号:8667635
-
项目类别:
-
资助金额:$38.16万
-
财政年份:2014
-
负责人:NANCY RATNER
-
依托单位:
2011 Neurofibromatosis (NF) Conference
-
批准号:8130153
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2011
-
负责人:NANCY RATNER
-
依托单位:
Cincinnati Neuro-Oncology Research Core
-
批准号:7859507
-
项目类别:
-
资助金额:$70.67万
-
财政年份:2009
-
负责人:NANCY RATNER
-
依托单位:
Cincinnati Neuro-Oncology Research Core
-
批准号:7944174
-
项目类别:
-
资助金额:$71.0万
-
财政年份:2009
-
负责人:NANCY RATNER
-
依托单位:
Cincinnati Center of Neurofibromatosis Research
-
批准号:8125764
-
项目类别:
-
资助金额:$10.41万
-
财政年份:2008
-
负责人:NANCY RATNER
-
依托单位:
Cincinnati Center of Neurofibromatosis Research
-
批准号:7911619
-
项目类别:
-
资助金额:$128.76万
-
财政年份:2008
-
负责人:NANCY RATNER
-
依托单位:
Cincinnati Center of Neurofibromatosis Research
-
批准号:8122235
-
项目类别:
-
资助金额:$139.34万
-
财政年份:2008
-
负责人:NANCY RATNER
-
依托单位:
Cincinnati Center of Neurofibromatosis Research
-
批准号:7509216
-
项目类别:
-
资助金额:$127.0万
-
财政年份:2008
-
负责人:NANCY RATNER
-
依托单位:
Cincinnati Center of Neurofibromatosis Research
-
批准号:7869573
-
项目类别:
-
资助金额:$19.72万
-
财政年份:2008
-
负责人:NANCY RATNER
-
依托单位:
Cincinnati Center of Neurofibromatosis Research
-
批准号:8305046
-
项目类别:
-
资助金额:$129.04万
-
财政年份:2008
-
负责人:NANCY RATNER
-
依托单位:
Cincinnati Center of Neurofibromatosis Research
-
批准号:7686754
-
项目类别:
-
资助金额:$128.62万
-
财政年份:2008
-
负责人:NANCY RATNER
-
依托单位:
Schwann Cells in Neurofibromatosis Type 2 (NF2)
-
批准号:7322665
-
项目类别:
-
资助金额:$28.5万
-
财政年份:2007
-
负责人:NANCY RATNER
-
依托单位:
Schwann Cells in Neurofibromatosis Type 2 (NF2)
-
批准号:7640723
-
项目类别:
-
资助金额:$28.5万
-
财政年份:2007
-
负责人:NANCY RATNER
-
依托单位:
Schwann Cells in Neurofibromatosis Type 2 (NF2)
-
批准号:8079451
-
项目类别:
-
资助金额:$27.65万
-
财政年份:2007
-
负责人:NANCY RATNER
-
依托单位:
海外基金